Schenk T - Search Results

1

Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib.

Ernst T, Erben P, Müller MC, Paschka P, Schenk T, Hoffmann J, Kreil S, La Rosée P, Hehlmann R, Hochhaus A. Ernst T, et al. Among authors: schenk t. Haematologica. 2008 Feb;93(2):186-92. doi: 10.3324/haematol.11993. Epub 2008 Jan 26. Haematologica. 2008. PMID: 18223278 Free article.

2

Cause and management of therapy resistance.

Hochhaus A, Schenk T, Erben P, Ernst T, La Rosée P, Müller MC. Hochhaus A, et al. Among authors: schenk t. Best Pract Res Clin Haematol. 2009 Sep;22(3):367-79. doi: 10.1016/j.beha.2009.05.004. Best Pract Res Clin Haematol. 2009. PMID: 19959087 Review.

3

Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy.

Hanfstein B, Müller MC, Kreil S, Ernst T, Schenk T, Lorentz C, Schwindel U, Leitner A, Hehlmann R, Hochhaus A. Hanfstein B, et al. Among authors: schenk t. Haematologica. 2011 Mar;96(3):360-6. doi: 10.3324/haematol.2010.030999. Epub 2010 Dec 6. Haematologica. 2011. PMID: 21134983 Free PMC article.

4

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity.

Härtel N, Klag T, Hanfstein B, Mueller MC, Schenk T, Erben P, Hochhaus A, La Rosée P. Härtel N, et al. Among authors: schenk t. J Cancer Res Clin Oncol. 2012 Feb;138(2):203-12. doi: 10.1007/s00432-011-1086-x. Epub 2011 Nov 17. J Cancer Res Clin Oncol. 2012. PMID: 22089930

5

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.

Müller MC, Erben P, Saglio G, Gottardi E, Nyvold CG, Schenk T, Ernst T, Lauber S, Kruth J, Hehlmann R, Hochhaus A; European LeukemiaNet. Müller MC, et al. Among authors: schenk t. Leukemia. 2008 Jan;22(1):96-102. doi: 10.1038/sj.leu.2404983. Epub 2007 Oct 18. Leukemia. 2008. PMID: 17943168

6

Harmonization of molecular monitoring of CML therapy in Europe.

Müller MC, Cross NC, Erben P, Schenk T, Hanfstein B, Ernst T, Hehlmann R, Branford S, Saglio G, Hochhaus A. Müller MC, et al. Among authors: schenk t. Leukemia. 2009 Nov;23(11):1957-63. doi: 10.1038/leu.2009.168. Epub 2009 Aug 27. Leukemia. 2009. PMID: 19710700 Review.

7

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib.

La Rosée P, Martiat P, Leitner A, Klag T, Müller MC, Erben P, Schenk T, Saussele S, Hochhaus A. La Rosée P, et al. Among authors: schenk t. Ann Hematol. 2013 Oct;92(10):1345-50. doi: 10.1007/s00277-013-1769-2. Epub 2013 Apr 28. Ann Hematol. 2013. PMID: 23625298

8

ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.

Schönfeld L, Rinke J, Hinze A, Nagel SN, Schäfer V, Schenk T, Fabisch C, Brümmendorf TH, Burchert A, le Coutre P, Krause SW, Saussele S, Safizadeh F, Pfirrmann M, Hochhaus A, Ernst T. Schönfeld L, et al. Among authors: schenk t. Leukemia. 2022 Sep;36(9):2242-2249. doi: 10.1038/s41375-022-01648-4. Epub 2022 Jul 28. Leukemia. 2022. PMID: 35902731 Free PMC article.

9

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors.

Klag T, Härtel N, Erben P, Schwaab J, Schnetzke U, Schenk T, Hochhaus A, La Rosée P. Klag T, et al. Among authors: schenk t. Leukemia. 2012 Jun;26(6):1321-8. doi: 10.1038/leu.2011.380. Epub 2012 Jan 13. Leukemia. 2012. PMID: 22289991

10

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry).

Möbius S, Schenk T, Himsel D, Maier J, Franke GN, Saussele S, Pott C, Andrikovics H, Meggyesi N, Machova-Polakova K, Zizkova H, Jurcek T, Mesanovic S, Zadro R, Gottardi E, Haenig J, Schuld P, Cross NCP, Hochhaus A, Ernst T. Möbius S, et al. Among authors: schenk t. J Cancer Res Clin Oncol. 2019 Jun;145(6):1645-1650. doi: 10.1007/s00432-019-02910-6. Epub 2019 Apr 2. J Cancer Res Clin Oncol. 2019. PMID: 30941573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

265 results

Search Page